[Response of patients with porphyria cutanea tarda to treatment with a regimen of delagil-riboxin].
L I
LI
Idel'son
G A
GA
Aziz
D000962:Antimalarials / Q000008:administration & dosage*; D002738:Chloroquine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007290:Inosine Diphosphate / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D017119:Porphyria Cutanea Tarda / Q000188:drug therapy*
D000962:Antimalarials; C023676:chloroquine diphosphate; D007290:Inosine Diphosphate; D002738:Chloroquine
Rezul'tat lecheniia bol'nykh urokoproporfirieĭ (pozdneĭ kozhnoĭ porfirieĭ) po skheme delagil-riboksin.